Chordia Therapeutics Balance Sheet

Financials in millions JPY. Fiscal year is September - August.

Millions JPY. Fiscal year is Sep - Aug.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023
Period Ending	May '26 May 31, 2026	Aug '25 Aug 31, 2025	Aug '24 Aug 31, 2024	Aug '23 Aug 31, 2023
Cash & Equivalents	2,507	2,549	4,330	4,799
Cash & Short-Term Investments	2,507	2,549	4,330	4,799
Cash Growth	-11.17%	-41.13%	-9.78%	-
Prepaid Expenses	21.77	24.9	38.16	52.06
Other Current Assets	45.15	95.18	237.64	40.52
Total Current Assets	2,573	2,669	4,605	4,892
Property, Plant & Equipment	-	-	2.75	4.43
Other Intangible Assets	-	-	0.62	2.5
Other Long-Term Assets	12.29	12.32	23.59	10.59
Total Assets	2,586	2,681	4,632	4,909
Accounts Payable	194.92	120.01	382.43	248.43
Accrued Expenses	0.36	29.33	2.3	25.6
Current Income Taxes Payable	1.43	90.5	54.29	2.42
Other Current Liabilities	56.06	4.5	32.06	131.79
Total Current Liabilities	252.76	244.34	471.07	408.24
Other Long-Term Liabilities	0	0	0	-
Total Liabilities	252.77	244.34	471.07	408.24
Common Stock	1,346	876.27	845.27	90
Additional Paid-In Capital	2,028	9,066	9,035	8,280
Retained Earnings	-1,048	-7,508	-5,722	-3,895
Comprehensive Income & Other	7.12	2.52	2.94	25.93
Shareholders' Equity	2,333	2,437	4,161	4,501
Total Liabilities & Equity	2,586	2,681	4,632	4,909
Net Cash (Debt)	2,507	2,549	4,330	4,799
Net Cash Growth	-11.17%	-41.13%	-9.78%	-
Net Cash Per Share	34.99	37.15	73.72	85.02
Filing Date Shares Outstanding	77.26	68.99	67.68	56.44
Total Common Shares Outstanding	77.26	68.99	67.68	56.44
Working Capital	2,321	2,425	4,134	4,483
Book Value Per Share	30.20	35.32	61.49	79.74
Tangible Book Value	2,333	2,437	4,161	4,498
Tangible Book Value Per Share	30.20	35.32	61.48	79.70
Machinery	10.48	10.48	11.21	10.68